Jim Simons Journey Medical Corp Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q2 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Journey Medical Corp stock. As of the latest transaction made, Renaissance Technologies LLC holds 243,500 shares of DERM stock, worth $2.08 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

243,500

Previous 238,000 2.31%

Holding current value

$2.08 Million

Previous $1.4 Million 24.5%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$5.97 - $8.07 $32,835 - $44,385	5,500 Added 2.31%	243,500 $1.75 Million
Q1 2025 May 14, 2025	BUY	$3.66 - $6.54 $7,320 - $13,080	2,000 Added 0.85%	238,000 $1.4 Million
Q4 2024 Feb 13, 2025	SELL	$3.97 - $6.53 $127,834 - $210,266	-32,200 Reduced 12.01%	236,000 $958,000
Q3 2024 Nov 13, 2024	BUY	$4.22 - $5.91 $17,618 - $24,674	4,175 Added 1.58%	268,200 $1.52 Million
Q2 2024 Aug 09, 2024	SELL	$3.31 - $5.94 $21,763 - $39,055	-6,575 Reduced 2.43%	264,025 $1.49 Million
Q1 2024 May 13, 2024	BUY	$2.92 - $5.47 $28,032 - $52,512	9,600 Added 3.68%	270,600 $996,000
Q4 2023 Feb 13, 2024	BUY	$2.7 - $7.96 $648,270 - $1.91 Million	240,100 Added 1148.8%	261,000 $1.5 Million
Q3 2023 Nov 14, 2023	BUY	$1.66 - $2.97 $15,604 - $27,918	9,400 Added 81.74%	20,900 $57,000
Q2 2023 Aug 11, 2023	BUY	$1.03 - $2.26 $11,845 - $25,989	11,500 New	11,500 $18,000
Q2 2022 Aug 12, 2022	SELL	$2.62 - $5.06 $40,872 - $78,936	-15,600 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$3.93 - $5.76 $61,308 - $89,856	15,600 New	15,600 $75,000

Others Institutions Holding DERM

# of Institutions

Shares Held

6.4M

Call Options Held

Put Options Held

View Full List

About Journey Medical Corp

Ticker DERM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 11,596,500
Market Cap $99M
Description
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...

More about DERM

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account